Analysis of the Mammographic and Sonographic Features of Pseudoangiomatous Stromal Hyperplasia
Gormlaith C. Hargaden1,2,
Eren D. Yeh1,3,
Dianne Georgian-Smith1,3,
Richard H. Moore1,
Elizabeth A. Rafferty1,
Elkan F. Halpern4 and
Grace T. McKee5
1 Division of Breast Imaging, Department of Radiology, Avon Comprehensive Breast
Center, Massachusetts General Hospital, Boston, MA.
2 Present address: Breast Check, Mater Misericordiae University Hospital, 36
Eccles St., Dublin 7, Ireland.
3 Present address: Division of Breast Imaging, Department of Radiology, Harvard
Medical School, Brigham and Women's Hospital, Boston, MA.
4 Institute for Technology Assessment, Massachusetts General Hospital, Boston,
MA.
5 Department of Pathology, Massachusetts General Hospital, Boston, MA.

View larger version (15K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 1 —Graph summarizes mammographic findings: normal, mass lesion
(circumscribed), focal asymmetric density, and incidental finding of
architectural distortion or calcifications. Light gray indicates screening
group; dark gray, clinical finding group.
|
|

View larger version (25K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 2 —Graph shows pathologic findings in screening group.
Pseudoangiomatous stromal hyperplasia was identified in all cases, either
alone or with invasive carcinoma, fibrocystic change, fibroadenoma, atypical
ductal hyperplasia, ductal carcinoma in situ, or another abnormality.
|
|

View larger version (26K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 3 —Graph shows pathologic findings in clinical group.
Pseudoangiomatous stromal hyperplasia was identified in all cases either alone
or with invasive carcinoma, fibrocystic change, fibroadenoma, atypical ductal
hyperplasia, ductal carcinoma in situ, or another abnormality.
|
|

View larger version (72K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4A —62-year-old postmenopausal woman not taking hormone
replacement therapy who underwent screening mammography. Screening mammogram
in extended craniocaudal (A) and mediolateral oblique (B) views
shows new focal asymmetric density (arrow) in left upper outer breast
compared with mammogram (not shown) obtained 3 years previously. It measures
approximately 2 cm, is low in x-ray attenuation, and has ill-defined margins.
Because it was new and has ill-defined margins, lesion is concerning for
malignancy, and biopsy was suggested. Results of needle localization and
surgical biopsy showed pseudoangiomatous stromal hyperplasia.
|
|

View larger version (81K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4B —62-year-old postmenopausal woman not taking hormone
replacement therapy who underwent screening mammography. Screening mammogram
in extended craniocaudal (A) and mediolateral oblique (B) views
shows new focal asymmetric density (arrow) in left upper outer breast
compared with mammogram (not shown) obtained 3 years previously. It measures
approximately 2 cm, is low in x-ray attenuation, and has ill-defined margins.
Because it was new and has ill-defined margins, lesion is concerning for
malignancy, and biopsy was suggested. Results of needle localization and
surgical biopsy showed pseudoangiomatous stromal hyperplasia.
|
|

View larger version (126K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 4C —62-year-old postmenopausal woman not taking hormone
replacement therapy who underwent screening mammography. Photomicrograph shows
typical pseudoangiomatous stromal hyperplasia: anastomosing slitlike empty
spaces lined by flattened myofibroblasts without RBCs. (H and E)
|
|

View larger version (71K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5A —53-year-old postmenopausal woman taking hormone replacement
therapy who has palpable lump. Craniocaudal (A) and mediolateral
oblique (B) mammograms of left breast show mass (arrow) in
retroareolar region, corresponding to patient's focal area of clinical
concern. Mass measures 3 cm and has partially well-circumscribed margins and
margins partially obscured by adjacent dense breast tissue.
|
|

View larger version (85K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5B —53-year-old postmenopausal woman taking hormone replacement
therapy who has palpable lump. Craniocaudal (A) and mediolateral
oblique (B) mammograms of left breast show mass (arrow) in
retroareolar region, corresponding to patient's focal area of clinical
concern. Mass measures 3 cm and has partially well-circumscribed margins and
margins partially obscured by adjacent dense breast tissue.
|
|

View larger version (98K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5C —53-year-old postmenopausal woman taking hormone replacement
therapy who has palpable lump. Focal sonogram corresponding to A and
B shows 2.9-cm solid hypoechoic oval mass with smooth
well-circumscribed margins and unusually internal cystic spaces.
Sonographically guided core biopsy and pathologic examination revealed dense
sclerosis and features suggestive of pseudoangiomatous stromal hyperplasia.
Surgical biopsy revealed pseudoangiomatous stromal hyperplasia with associated
fibrocystic changes. Crosses delineate lesion.
|
|

View larger version (97K):
[in this window]
[in a new window]
[as a PowerPoint slide]
|
Fig. 5D —53-year-old postmenopausal woman taking hormone replacement
therapy who has palpable lump. High-power photomicrograph shows lesion more
cellular than that in Figures
4A,
4B, and
4C. Slitlike spaces are
collapsed or compressed, and many plump myofibroblasts are present. Dense
collagenous stroma separates spaces. (H and E)
|
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Copyright © 2008 by the American Roentgen Ray Society.